Advanced search
Publication Cover
Clinical and Experimental Hypertension Volume 39, 2017 - Issue 3
Submit an article Journal homepage
191
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Renal denervation decreases blood pressure and renal tyrosine hydroxylase but does not augment the effect of hypotensive drugs

Janusz SkrzypeckiDepartment of Experimental Physiology and Pathophysiology, Laboratory of Center for Preclinical Research, Medical University of Warsaw, Warsaw, PolandView further author information
,
Maciej GawlakLaboratory of Physiology and Pathophysiology, Center for Preclinical Research, Medical University of Warsaw, Warsaw, PolandView further author information
,
Tomasz HucDepartment of Experimental Physiology and Pathophysiology, Laboratory of Center for Preclinical Research, Medical University of Warsaw, Warsaw, PolandView further author information
,
Paweł SzulczykLaboratory of Physiology and Pathophysiology, Center for Preclinical Research, Medical University of Warsaw, Warsaw, PolandView further author information
&
Marcin UfnalDepartment of Experimental Physiology and Pathophysiology, Laboratory of Center for Preclinical Research, Medical University of Warsaw, Warsaw, PolandCorrespondence[email protected]
View further author information
Pages 290-294 | Received 13 Aug 2016, Accepted 21 Nov 2016, Published online: 27 Apr 2017

References

  • Krum H, Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 2009;373:1275–81.
  • Esler MD, Krum H, Sobotka PA, et al. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 2010;376:1903–9.
  • Esler MD, Krum H, Schlaich M, et al. Symplicity HTNI. Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial. Circulation 2012;126:2976–82.
  • Bhatt DL, Kandzari DE, O’Neill WW, et al. A controlled trial of renal denervation for resistant hypertension. N Engl J Med 2014;370:1393–401.
  • Skrzypecki J, Ufnal M. Drug resistant hypertension - no simple way out. Kidney Blood Press Res 2015;40:66–76.
  • Kandzari DE, Bhatt DL, Brar S, et al. Predictors of blood pressure response in the SYMPLICITY HTN-3 trial. Eur Heart J 2015;36:219–27.
  • Ufnal M. Essential hypertension–is erroneous receptor output to blame? Med Hypotheses 2012;78:454–8.
  • Ram CV. Beta-blockers in hypertension. Am J Cardiol 2010;106:1819–25.
  • Johnston CI. Angiotensin receptor antagonists: focus on losartan. Lancet 1995;346:1403–7.
  • DiBona GF, Kopp UC. Neural control of renal function. Physiol Rev 1997;77:75–197.
  • Foss JD, Wainford RD, Engeland WC, et al. A novel method of selective ablation of afferent renal nerves by periaxonal application of capsaicin. Am J Physiol Regul Integr Comp Physiol 2015;308(2):R112–22.
  • Liu W, Wang W, Song SW, et al. Synergism of telmisartan and amlodipine on blood pressure reduction and cardiorenal protection in hypertensive rats. J Cardiovasc Pharmacol 2011;57:308–16.
  • Kawano Y, Yoshida K, Matsuoka H, Omae T. Chronic effects of central and systemic administration of losartan on blood pressure and baroreceptor reflex in spontaneously hypertensive rats. Am J Hypertens 1994;7:536–42.
  • Kline RL, Stuart PJ, Mercer PF. Effect of renal denervation on arterial pressure and renal norepinephrine concentration in Wistar-Kyoto and spontaneously hypertensive rats. Can J Physiol Pharmacol 1980;58:1384–8.
  • Bennett T, Gardiner SM. Prevention and reversal of isolation-induced systolic arterial hypertension in rats by treatment with beta-adrenoceptor antagonists. Br J Pharmacol 1979;65:205–13.
  • Ufnal M, Dudek M, Szczepanska-Sadowska E. Inhibition of brain nitric oxide synthesis enhances and prolongs the hypertensive effect of centrally administered interleukin-1beta in rats. Cytokine 2006;33:166–70.
  • Veelken R, Vogel EM, Hilgers K, et al. Autonomic renal denervation ameliorates experimental glomerulonephritis. J Am Soc Nephrol 2008;19:1371–8.
  • Sakakura K, Ladich E, Edelman ER, et al. Methodological standardization for the pre-clinical evaluation of renal sympathetic denervation. JACC Cardiovasc Interv 2014;7:1184–93.
  • Pires NM, Igreja B, Moura E, et al. Blood pressure decrease in spontaneously hypertensive rats following renal denervation or dopamine beta-hydroxylase inhibition with etamicastat. Hypertens Res 2015;38:605–12.
  • Lee JY, Walsh GM. Systemic and regional haemodynamic effects of renal denervation in spontaneously hypertensive rats. J Hypertens 1983;1:381–6.
  • Kline RL, Kelton PM, Mercer PF. Effect of renal denervation on the development of hypertension in spontaneously hypertensive rats. Can J Physiol Pharmacol 1978;56:818–22.
  • Kandzari DE, Kario K, Mahfoud F, et al. The SPYRAL HTN Global Clinical Trial Program: Rationale and design for studies of renal denervation in the absence (SPYRAL HTN OFF-MED) and presence (SPYRAL HTN ON-MED) of antihypertensive medications American Heart Journal 2016;171:82–91.
  • DiBona GF, Esler M. Translational medicine: the antihypertensive effect of renal denervation. Am J Physiol Regul Integr Comp Physiol 2010;298:R245–53.
  • Campbell DB, Moore RA. The pharmacology and clinical pharmacology of indapamide. Postgrad Med J 1981;57(Suppl 2):7–17.
  • Kopp U, DiBona GF. Interaction of renal beta 1-adrenoceptors and prostaglandins in reflex renin release. Am J Physiol 1983;244:F418–24.
  • DiBona GF, Sawin LL. Effect of metoprolol administration on renal sodium handling in experimental congestive heart failure. Circulation 1999;100(1):82–6.
  • Ukena C, Mahfoud F, Linz D, et al. Potential role of renal sympathetic denervation for the treatment of cardiac arrhythmias. Euro Intervention 2013;9(SupplR):R110–6.
  • Stauss HM. Heart rate variability. Am J Physiol Regul Integr Comp Physiol 2003;285:R927–31.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.